Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
---|---|---|---|---|---|---|
Teva | Alendronic acid | Alendronate |  | 2008-02-06 |  |  |
Ibandronic acid | Ibandronic Acid Teva |  | 2010-09-17 |  |  | |
Raloxifene | Raloxifene |  | 2014-03-04 |  |  | |
Raloxifene | Raloxifene Teva |  | 2010-04-29 |  |  | |
Zoledronic acid | Zoledronic acid Teva Pharma |  | 2012-08-15 |  |  | |
Teriparatide | Teriparatide |  | 2023-11-16 |  |  | |
Glenmark Pharmaceuticals | Raloxifene | Raloxifene |  | 2016-03-22 |  |  |
Mylan | Alendronic acid | Alendronate |  | 2008-08-04 |  |  |
Ibandronic acid | Ibandronate |  | 2012-03-19 |  |  | |
Roche | Ibandronic acid | Bondenza (previously Ibandronic Acid Roche) |  | 2004-02-23 |  |  |
Ibandronic acid | Boniva | 2023-05-06 | 2003-05-16 |  |  | |
Ibandronic acid | Destara |  | 1996-06-25 |  |  | |
Cipla | Alendronic acid | Alendronate |  | 2008-08-04 |  |  |
Raloxifene | Raloxifene |  | 2014-09-24 |  |  | |
Sandoz | Zoledronic acid | Aclasta |  | 2005-04-15 |  |  |
Ibandronic acid | Ibandronic Acid Sandoz |  | 2011-07-26 |  |  | |
Organon | Alendronic acid, Cholecalciferol | Adrovance |  | 2007-01-04 |  |  |
Alendronic acid | Fosamax |  | 1995-09-29 | $144 M | Q2/24-Q1/25 | |
Alendronic acid, Cholecalciferol | Fosamax D |  | 2005-04-07 |  |  | |
Alendronic acid, Cholecalciferol | Fosavance |  | 2005-08-24 |  |  | |
Alendronic acid, Cholecalciferol | Vantavo (previously Alendronate colecalciferol, MSD) |  | 2009-10-16 |  |  | |
Sanofi | Teriparatide | Parathar |  | 1987-12-23 |  |  |
UCB | Romosozumab | Evenity |  | 2019-12-09 |  |  |
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
---|---|---|---|---|---|